THE Therapeutic Goods
Administration has approved a new
orphan drug designation for
Novartis Pharmaceuticals Afinitor
(everolimus) 5mg and 10mg
tablets, indicated for use in the
treatment of advanced renal cell
carcinoma.
For more info- www.tga.gov.au.The above article was sent to subscribers in Pharmacy Daily's issue from 02 Aug 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Aug 10
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.